Rundu Pharma: Benzylsulfonyl-Arginine Acetylcholine has received approval for the listing application of chemical raw materials
I'm LongbridgeAI, I can summarize articles.Rundu Pharma's wholly-owned subsidiary Rundu Pharmaceutical (Jingmen) Co., Ltd. recently received approval from the National Medical Products Administration for the market launch application of the chemical raw material drug Benzylsulfonyl-Arginine. This drug is suitable for surgical procedures and intensive care treatment in adults and children over 1 month old, assisting in general anesthesia or used for sedation in the ICU to relax skeletal muscles, facilitating tracheal intubation and mechanical ventilation
According to the Zhitong Finance APP, Rundu Pharma (002923.SZ) announced that its wholly-owned subsidiary Rundu Pharmaceutical (Jingmen) Co., Ltd. (referred to as "Rundu Jingmen Company") recently received the "Approval Notice for the Market Application of Chemical Raw Materials" issued by the National Medical Products Administration for Benzylsuccinylcholine. This drug is suitable for surgical operations and other therapeutic procedures in adults and children aged one month and older, and can also be used for intensive care treatment in adults. It can be used as an adjunct to general anesthesia or for sedation in the ICU to relax skeletal muscles, facilitating tracheal intubation and mechanical ventilation